MODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Modular Medical, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.07−0.25 (-10.58%)
Close on Oct 19, 2026
- Market cap
- $11.29M
- P/E (TTM)
- –
- Dividend yield
- –
Margins need revenue and profit figures
This company does not report the lines needed to calculate margins.
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2015 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 21.1% | -920.4% | -188.1% | |
| Return on assets | -2479.5% | -241.6% | -168.3% | |
| Current ratio | 0.02 | 0.50 | 4.03 | |
| Interest coverage | – | -184.4× | – | |
| Diluted shares | 0M | 0M | 2M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Modular Medical generated $74.70M from operations and spent $9.82M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$74.70M
Used
$9.82M
Capital expenditure$9.82M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
1of 6 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$28.24M
- Cash generatingOperating cash flow above zero-$23.75M
- Return on assets improvedROA up on the prior year-136.3% → -150.7%
- Earnings backed by cashOperating cash flow above net income-$23.75M vs -$28.24M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose10.69 → 4.03
- No dilutionShare count did not rise1M → 2M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –